0001127602-24-001443.txt : 20240117
0001127602-24-001443.hdr.sgml : 20240117
20240117164727
ACCESSION NUMBER: 0001127602-24-001443
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240116
FILED AS OF DATE: 20240117
DATE AS OF CHANGE: 20240117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deschatelets Pascal
CENTRAL INDEX KEY: 0001657720
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 24539046
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-01-16
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001657720
Deschatelets Pascal
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Chief Scientific Officer
0
Common Stock
2024-01-16
4
A
0
6743
0
A
1123550
D
Common Stock
2024-01-16
4
S
0
1632
66.8086
D
1121918
D
Stock Option (Right to Buy)
66.30
2024-01-16
4
A
0
9805
66.30
A
2034-01-15
Common Stock
9805
9805
D
This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/12/2024.
This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.
/s/ David Watson, attorney-in-fact for Pascal Deschatelets
2024-01-17